UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Form 10-Q
|
(Mark One)
|
||
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the quarterly period ended September 30, 2004 | ||
| or | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the transition period from to | ||
Commission file number: 0-20558
McAfee, Inc.
|
Delaware
|
77-0316593 | |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
|
|
3965 Freedom Circle Santa Clara,
California
|
95054 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrants telephone number, including area code:
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes þ No o
As of November 4, 2004, 160,192,233 shares of the registrants common stock, $0.01 par value, were outstanding.
THIS DOCUMENT CONTAINS 73 PAGES.
MCAFEE, INC.
Form 10-Q
CONTENTS
1
MCAFEE, INC. AND SUBSIDIARIES
| September 30, | December 31, | |||||||||
| 2004 | 2003 | |||||||||
| (In thousands, except | ||||||||||
| share and per share data) | ||||||||||
| (Unaudited) | ||||||||||
| ASSETS | ||||||||||
|
Current assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 340,408 | $ | 333,651 | ||||||
|
Short-term marketable securities
|
188,435 | 174,499 | ||||||||
|
Accounts receivable, net
|
87,243 | 170,218 | ||||||||
|
Prepaid expenses, income taxes and other current
assets
|
97,920 | 97,616 | ||||||||
|
Deferred taxes
|
172,069 | 160,550 | ||||||||
|
Assets held for sale
|
| 24,719 | ||||||||
|
Total current assets
|
886,075 | 961,253 | ||||||||
|
Long-term marketable securities
|
318,190 | 258,107 | ||||||||
|
Restricted cash
|
20,282 | 20,547 | ||||||||
|
Property and equipment, net
|
96,971 | 111,672 | ||||||||
|
Deferred taxes
|
112,414 | 199,196 | ||||||||
|
Intangible assets, net
|
85,953 | 105,952 | ||||||||
|
Goodwill
|
391,324 | 443,593 | ||||||||
|
Other assets
|
7,927 | 20,178 | ||||||||
|
Total assets
|
$ | 1,919,136 | $ | 2,120,498 | ||||||
| LIABILITIES | ||||||||||
|
Current liabilities:
|
||||||||||
|
Accounts payable
|
$ | 21,760 | $ | 32,099 | ||||||
|
Accrued liabilities
|
117,671 | 148,875 | ||||||||
|
Deferred revenue
|
421,939 | 342,795 | ||||||||
|
Liabilities related to assets held for sale
|
| 23,310 | ||||||||
|
Total current liabilities
|
561,370 | 547,079 | ||||||||
|
Deferred revenue, less current portion
|
99,188 | 116,762 | ||||||||
|
Convertible debt
|
| 347,397 | ||||||||
|
Other long term liabilities
|
193,604 | 221,171 | ||||||||
|
Total liabilities
|
854,162 | 1,232,409 | ||||||||
|
Commitments and contingencies (Notes 11 and
12)
|
||||||||||
| STOCKHOLDERS EQUITY | ||||||||||
|
Preferred stock, $0.01 par value:
|
||||||||||
|
Authorized: 5,000,000 shares; Issued and
outstanding:
|
||||||||||
|
none
|
| | ||||||||
|
Common stock, $0.01 par value:
|
||||||||||
|
Authorized: 300,000,000 shares; Issued:
168,294,143 shares and 162,071,798 shares at
September 30, 2004 and December 31, 2003, respectively;
|
||||||||||
|
Outstanding: 159,280,943 shares and
161,721,798 shares at September 30, 2004 and
December 31, 2003, respectively
|
1,683 | 1,621 | ||||||||
|
Additional paid-in capital
|
1,226,221 | 1,087,625 | ||||||||
|
Deferred stock-based compensation
|
(268 | ) | (598 | ) | ||||||
|
Accumulated other comprehensive income
|
30,871 | 34,027 | ||||||||
|
Accumulated deficit
|
(43,561 | ) | (229,879 | ) | ||||||
|
Treasury stock, at cost: 9,013,200 shares
and 350,000 shares at September 30, 2004 and
December 31, 2003, respectively
|
(149,972 | ) | (4,707 | ) | ||||||
|
Total stockholders equity
|
1,064,974 | 888,089 | ||||||||
|
Total liabilities and stockholders equity
|
$ | 1,919,136 | $ | 2,120,498 | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
MCAFEE, INC. AND SUBSIDIARIES
| Three Months Ended | Nine Months Ended | |||||||||||||||||
| September 30, | September 30, | |||||||||||||||||
| 2004 | 2003 | 2004 | 2003 | |||||||||||||||
| (In thousands, except per share data) | ||||||||||||||||||
| (Unaudited) | ||||||||||||||||||
| (As Restated, | (As Restated, | |||||||||||||||||
| See Note 13) | See Note 13) | |||||||||||||||||
|
Net revenue:
|
||||||||||||||||||
|
Product
|
$ | 65,518 | $ | 120,371 | $ | 229,256 | $ | 366,881 | ||||||||||
|
Services and support
|
156,115 | 107,404 | 437,133 | 297,233 | ||||||||||||||
|
Total net revenue
|
221,633 | 227,775 | 666,389 | 664,114 | ||||||||||||||
|
Cost of net revenue:
|
||||||||||||||||||
|
Product
|
21,935 | 22,484 | 69,383 | 61,539 | ||||||||||||||
|
Services and support
|
9,526 | 12,016 | 30,165 | 38,248 | ||||||||||||||
|
Amortization of purchased technology
|
2,812 | 3,435 | 9,481 | 7,952 | ||||||||||||||
|
Total cost of net revenue
|
34,273 | 37,935 | 109,029 | 107,739 | ||||||||||||||
|
Operating costs:
|
||||||||||||||||||
|
Research and development(1)
|
38,989 | 46,705 | 128,714 | 138,087 | ||||||||||||||
|
Marketing and sales(2)
|
82,945 | 91,405 | 272,017 | 267,105 | ||||||||||||||
|
General and administrative(3)
|
33,562 | 37,743 | 96,672 | 96,643 | ||||||||||||||
|
Reimbursement from transition services agreement
|
(3,671 | ) | | (3,671 | ) | | ||||||||||||
|
(Gain) loss on sale of assets and technology
|
(195,875 | ) | | (241,279 | ) | 867 | ||||||||||||
|
Reimbursement related to litigation settlement
|
| | (24,991 | ) | | |||||||||||||
|
Severance costs related to Sniffer disposition(4)
|
8,696 | | 8,696 | | ||||||||||||||
|
Amortization of intangibles
|
3,448 | 3,637 | 10,537 | 12,369 | ||||||||||||||
|
Restructuring charge
|
8,549 | 257 | 11,421 | 22,864 | ||||||||||||||
|
In-process research and development
|
| | | 6,600 | ||||||||||||||
|
Total operating costs
|
(23,357 | ) | 179,747 | 258,116 | 544,535 | |||||||||||||
|
Income from operations
|
210,717 | 10,093 | 299,244 | 11,840 | ||||||||||||||
|
Interest and other income
|
4,591 | 4,174 | 13,166 | 13,190 | ||||||||||||||
|
Interest and other expenses
|
(540 | ) | (1,222 | ) | (3,418 | ) | (6,427 | ) | ||||||||||
|
Loss on redemption of convertible debt
|
(15,070 | ) | | (15,070 | ) | (2,727 | ) | |||||||||||
|
Gain (loss) on sale of marketable securities
|
(241 | ) | 223 | (1,072 | ) | 1,771 | ||||||||||||
|
Income before provision for income taxes and
cumulative effect of change in accounting principle
|
199,457 | 13,268 | 292,850 | 17,647 | ||||||||||||||
|
Provision for income taxes
|
81,309 | 2,494 | 106,532 | 3,050 | ||||||||||||||
|
Income before cumulative effect of change in
accounting principle
|
118,148 | 10,774 | 186,318 | 14,597 | ||||||||||||||
|
Cumulative effect of change in accounting
principle, net of tax
|
| | | 11,142 | ||||||||||||||
|
Net income
|
$ | 118,148 | $ | 10,774 | $ | 186,318 | $ | 25,739 | ||||||||||
|
Other comprehensive income:
|
||||||||||||||||||
|
Unrealized gain (loss) on marketable securities,
net
|
$ | 843 | $ | 767 | $ | (1,280 | ) | $ | 1 | |||||||||
|
Foreign currency translation (loss) gain
|
(545 | ) | 82 | (1,878 | ) | 10,567 | ||||||||||||
|
Comprehensive income
|
$ | 118,446 | $ | 11,623 | $ | 183,160 | $ | 36,307 | ||||||||||
|
Basic income per share:
|
||||||||||||||||||
|
Income before cumulative effect of change in
accounting principle
|
$ | 0.75 | $ | 0.07 | $ | 1.16 | $ | 0.09 | ||||||||||
|
Cumulative effect of change in accounting
principle, net of taxes
|
| | | 0.07 | ||||||||||||||
|
Net income per share basic
|
$ | 0.75 | $ | 0.07 | $ | 1.16 | $ | 0.16 | ||||||||||
|
Shares used in per share calculation
basic
|
158,151 | 160,347 | 160,321 | 160,086 | ||||||||||||||
|
Diluted income per share:
|
||||||||||||||||||
|
Income before cumulative effect of change in
accounting principle
|
$ | 0.70 | $ | 0.07 | $ | 1.08 | $ | 0.09 | ||||||||||
|
Cumulative effect of change in accounting
principle, net of taxes
|
| | | 0.07 | ||||||||||||||
|
Net income per share diluted
|
$ | 0.70 | $ | 0.07 | $ | 1.08 | $ | 0.16 | ||||||||||
|
Shares used in per share calculation
diluted
|
172,103 | 164,141 | 180,192 | 164,398 | ||||||||||||||
| (1) | Includes stock-based compensation charges of $575 and $2,202 for the three months ended September 30, 2004 and 2003, respectively, and $2,147 and $3,520 for the nine months ended September 30, 2004 and 2003, respectively. |
| (2) | Includes stock-based compensation charges of $203 and $2,795 for the three months ended September 30, 2004 and 2003, respectively, and $890 and $3,209 for the nine months ended September 30, 2004 and 2003, respectively. |
| (3) | Includes stock-based compensation charges of $485 and $839 for the three months ended September 30, 2004 and 2003, respectively, and $892 and $2,033 for the nine months ended September 30, 2004 and 2003, respectively. |
| (4) | Includes stock-based compensation charges of $991 for the three and nine months ended September 30, 2004. |
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
MCAFEE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | ||||||||||||
| September 30, | ||||||||||||
| 2004 | 2003 | |||||||||||
| (In thousands) | ||||||||||||
| (Unaudited) | ||||||||||||
| (As Restated, | ||||||||||||
| see Note 13) | ||||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income
|
$ | 186,318 | $ | 25,739 | ||||||||
|
Adjustments to reconcile net income to net cash
provided by operating activities:
|
||||||||||||
|
Cumulative effect of change in accounting
principle
|
| (11,142 | ) | |||||||||
|
Depreciation and amortization
|
49,615 | 46,507 | ||||||||||
|
Acquired in-process research and development
|
| 6,600 | ||||||||||
|
Non-cash interest expense on convertible notes
|
1,225 | 2,637 | ||||||||||
|
Premium amortization on marketable securities
|
3,916 | | ||||||||||
|
(Gain) loss on sale of assets and technology
|
(241,279 | ) | 867 | |||||||||
|
Loss (gain) on sale of marketable securities
|
1,072 | (1,771 | ) | |||||||||
|
Loss on redemption of convertible debt
|
15,070 | 2,727 | ||||||||||
|
Deferred taxes
< | ||||||||||||